5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Technology (Electrochemical Biosensors, Optical Biosensors, Thermal Biosensors, Piezoelectric Biosensors), Application, and Geography.
Fastest Growing Market:
Greater Than 6.7 %
A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals. Molecular biosensors are, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread
In recent years, due to ti increasing prevalence of chronic diseases, demand for point-of-care diagnostics has increased. This has led to an increase in demand for molecular biosensors. The factors have resulted in increased adoption of the molecular biosensor, which has helped the market growth.
However, high costs involved in research and development and strict regulatory guidelines to by authorities dissuade many manufacturers to enter the market. This has hindered the growth rate of the market.
A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by electrical, thermal or optical signals and is, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis.
In the report, a detailed analysis of the market is provided. The market is evaluated by collating revenues generated across segments, categorized by Technology, Application, and Geography.
|Food and Beverages|
|Defense and Security|
Report scope can be customized per your requirements. Click here.
Electrochemical biosensors have emerged as reliable molecular sensing devices suitable for the detection of pathogens in liquid biopsies. Short assay time, simple handling, low cost, small sample requirement, the ibility of multiplexing and miniaturization and good performance in complex samples with minimal pre-treatments justify their increasing growing and suitability for POC applications. These biosensors are able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread.
Pathogens are microorganisms that cause infectious disease. Bacteria and viruses are the main pathogens. Bacteria release toxins, and viruses damage cells. White blood cells destroy pathogens by ingestion or producing antibodies against them and antitoxins to neutralize toxins. Recently, due to unhealthy living conditions, especially in developing and underdeveloped countries, the incidence of bacterial infection has increased. Even in developed countries like the United States, the incidence of campylobacter gram-negative bacteria infection increased from 12.82 in 2004 to 12.97 in 2009 to 13.29 in 2014, according to a 2016 report by the Centers for Disease Control and Prevention.
Hence with increase in infection from pathogens, the demand for fast PoC diagnostics like electrochemical biosensors is expected to increase
To understand key trends, Download Sample Report
The North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high and increasing demand is met by the presence of global players in the region, the market is further expected to increase.
To understand geography trends, Download Sample Report.
Majority of the molecular biosensors are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic and Lifestyle Induced Diseases
4.2.2 Increasing Demand for Point of Care Testing
4.2.3 Increasing Application of Biosensors in Various Industries
4.3 Market Restraints
4.3.1 Strict Regulatory Requirements for Biosensors
4.3.2 High Cost Involved in Research and Development
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Technology
5.1.1 Electrochemical Biosensors
5.1.2 Optical Biosensors
5.1.3 Thermal Biosensors
5.2 By Application
5.2.1 Medical Diagnostics
5.2.2 Food and Beverages
5.2.3 Environment Safety
5.2.4 Defense and Security
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle-East and Africa
5.3.5 South America
220.127.116.11 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories Inc.
6.1.2 Dynamic Biosensors GmbH
6.1.3 Bio-Rad Laboratories Inc
6.1.4 F. Hoffmann La Roche
6.1.5 Johnson and Johnson
6.1.6 LifeSensors Inc.
6.1.7 Medtronic Inc.
6.1.8 Nova biomedical Corporation
6.1.9 Siemens Healthcare
6.1.10 Sysmex Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments